Cargando…

Expression Characteristics of Hypoxia-Inducible Factor-1α and Its Clinical Values in Diagnosis and Prognosis of Hepatocellular Carcinoma

BACKGROUND: Hypoxia-inducible factor-1 (HIF-1) is a ubiquitously expressed oxygen-regulated transcription factor composed of α and β subunits. HIF-1 activates the transcription of various genes including those involved in the formation and metastatic growth of hepatocellular carcinoma (HCC). OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shanshan, Yao, Dengfu, Wang, Li, Wu, Wei, Qiu, Liwei, Yao, Min, Yao, Ninghua, Zhang, Haijian, Yu, Dandan, Ni, Qichao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234574/ https://www.ncbi.nlm.nih.gov/pubmed/22224081 http://dx.doi.org/10.5812/kowsar.1735143X.771

Ejemplares similares

Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis
por: Sai, Wenli, et al.
Publicado: (2015)

High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma
por: Zheng, Wenjie, et al.
Publicado: (2018)

Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
por: Wang, Li, et al.
Publicado: (2013)

Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma
por: Wang, Li, et al.
Publicado: (2016)

Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target
por: Zheng, Wenjie, et al.
Publicado: (2016)

Targeted glypican-3 gene transcription inhibited the proliferation of human hepatoma cells by specific short hairpin RNA
por: Yu, Dandan, et al.
Publicado: (2012)

An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma
por: Yao, Ninghua, et al.
Publicado: (2023)

Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis
por: DONG, ZHIZHEN, et al.
Publicado: (2014)

A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma
por: Dai, Xiaoyan, et al.
Publicado: (2021)

Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy
por: Yao, Yongrong, et al.
Publicado: (2022)

Secretory clusterin promotes hepatocellular carcinoma progression by facilitating cancer stem cell properties via AKT/GSK-3β/β-catenin axis
por: Zheng, Wenjie, et al.
Publicado: (2020)

Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma
por: Xie, Hongjun, et al.
Publicado: (2022)

Oncogenic Wnt3a: A Candidate Specific Marker and Novel Molecular Target for Hepatocellular Carcinoma
por: Zheng, Wenjie, et al.
Publicado: (2019)

Evaluation of nuclear PGAM2 value in hepatocellular carcinoma prognosis
por: Li, Yi-Ran, et al.
Publicado: (2021)

Correlation of the AKT/mTOR signaling pathway with the clinicopathological features and prognosis of nasopharyngeal carcinoma
por: Wang, Yan, et al.
Publicado: (2021)

Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma
por: Wang, Xiaodong, et al.
Publicado: (2022)

The Value of Pulmonary Bedside Ultrasound System in the Evaluation of Severity and Prognosis of Acute Lung Injury
por: Li, Lei, et al.
Publicado: (2022)

CD8(+) T-cell exhaustion in the tumor microenvironment of head and neck squamous cell carcinoma determines poor prognosis
por: Zhang, Yijian, et al.
Publicado: (2022)

High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma
por: Zhang, Haijian, et al.
Publicado: (2017)

A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients
por: Zhang, Baohui, et al.
Publicado: (2020)

Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma
por: Zhang, Yijian, et al.
Publicado: (2021)

Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation
por: Gu, Juanjuan, et al.
Publicado: (2016)

Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy
por: Xu, Feng, et al.
Publicado: (2019)

WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma
por: Liang, Linjun, et al.
Publicado: (2022)

The value of histopathology combined with CapitalBio Mycobacterium real-time polymerase chain reaction test for diagnosing spinal tuberculosis
por: Yao, Liwei, et al.
Publicado: (2023)

Prognosis value of Hypoxia-inducible factor-1α expression in patients with bone and soft tissue sarcoma: a meta-analysis
por: Li, Yongjiang, et al.
Publicado: (2016)

Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4
por: Li, Qi, et al.
Publicado: (2016)

Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma
por: Li, Quanxiao, et al.
Publicado: (2021)

Progressive and Prognosis Value of Notch Receptors and Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
por: Zhang, Yingshi, et al.
Publicado: (2017)

An inflammation‐associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma
por: Ruan, Wan‐Yuan, et al.
Publicado: (2023)

The prognostic value of hypoxia-inducible factor-1α in advanced cancer survivors: a meta-analysis with trial sequential analysis
por: Han, Susu, et al.
Publicado: (2019)

LAMP1 expression is associated with poor prognosis in breast cancer
por: Wang, Qingqing, et al.
Publicado: (2017)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

Upregulation of hypoxia-inducible factor 1α mRNA expression was associated with poor prognosis in patients with hepatocellular carcinoma
por: Cheng, Wei, et al.
Publicado: (2019)

Co-expression of KIAA1199 and hypoxia-inducible factor 1α is a biomarker for an unfavorable prognosis in hepatocellular carcinoma
por: Wang, Dan, et al.
Publicado: (2020)

Predictive value of hypoxia, metabolism and immune factors for prognosis in hepatocellular carcinoma: a retrospective analysis and multicenter validation study
por: Lin, Peng, et al.
Publicado: (2020)

Providing higher value care for hepatocellular carcinoma rather than diagnosis: What can current radiologists do?
por: Yao, Shan, et al.
Publicado: (2022)

Clinical value of serum AFP and PIVKA‐II for diagnosis, treatment and prognosis of hepatocellular carcinoma
por: Tian, Shan, et al.
Publicado: (2022)

Development and Validation of Ferroptosis-Related lncRNAs as Prognosis and Diagnosis Biomarkers for Breast Cancer
por: Yao, Zhi-Yong, et al.
Publicado: (2022)

Dishevelled Associated Activator Of Morphogenesis (DAAM) Facilitates Invasion of Hepatocellular Carcinoma by Upregulating Hypoxia-Inducible Factor 1α (HIF-1α) Expression
por: Fang, Xiaoxu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u8d392e5g7ek4o6c049ss0q34r